GPR35 Agonist Compounds

The disclosures herein relate to novel compounds of formula (1):and salts and any tautomers thereof, wherein X, R1 and R2 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR35 receptors.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BROWN, Giles Albert, CONGREVE, Miles Stuart, WHITEHURST, Benjamin, SWAIN, Nigel Alan, FLANGAN, Neil John
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosures herein relate to novel compounds of formula (1):and salts and any tautomers thereof, wherein X, R1 and R2 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR35 receptors.